Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tractus Vascular is a private U.S. medical device company developing and commercializing endovascular catheter systems for crossing difficult arterial and venous occlusions. Its products are designed for chronic total occlusion and partial occlusion procedures, with an emphasis on improved pushability, trackability, and catheter shaft performance in challenging anatomy. The company’s core differentiated technology is its proprietary Jigsaw Technology, a laser-cut stainless-steel shaft architecture used in its crossing catheter portfolio. Publicly disclosed products include the Tractus Crossing Support Catheter and the Tunnel Crossing Catheter, both of which have received FDA 510(k) clearance. Tractus appears focused on peripheral vascular intervention rather than drug development, serving interventional physicians treating peripheral arterial and venous disease.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tractus Vascular.